COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,646 Articles (22,913 medRxiv, 8,733 bioRxiv)

Most recent first Previous |  Page 1068: Articles 10671-10680  | Next

Prediction of SARS-CoV-2 Omicron Variant Immunogenicity, Immune Escape and Pathogenicity, through Analysis of Spike Protein-specific Core Unique Peptides
Pierros, V., KONTOPODIS, E., STRAVOPODIS, D. J., TSANGARIS, G. T.
10.1101/2021.12.26.21268418 — Posted: 2021-12-29
SARS-CoV-2 Omicron variant: healthcare workers' perceptions and beliefs of vaccine effectiveness and advocacy: a national survey during the first week of the World Health Organization variant alert
Temsah, M.-H., Aljamaan, F., Alenezi, S., Alhasan, K., Alrabiaah, A., Assiri, R., Bassrawi, R., Alhaboob, A., Alshahrani, F., Al-Arabi, M., Alaraj, A., Alharbi, N. S., Halwani, R., Jamal, A., Al-Eyadhy, A., Abdulmajeed, N., Alfarra, L., Almashdali, W., AlZamil, F., Barry, M., Memish, Z. A., Al-Tawfiq, J. A., Al-Subaie, S.
10.1101/2021.12.27.21268431 — Posted: 2021-12-29
Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract
Saud, Z., PONSFORD, M. J., Bentley, K., Cole, J., Pandey, M., Jolles, S., Fegan, C., Humphreys, I., Wise, M., Stanton, R. J.
10.1101/2021.12.27.21268312 — Posted: 2021-12-29
Relationship between temperature and relative humidity on the initial spread of COVID-19 cases and deaths in Brazil
Olinto, M. T. A., Garcez, A., Brunelli, G., Olinto, F. A., Fanton, M., Canuto, R.
10.1101/2021.12.26.21268421 — Posted: 2021-12-29
Replacement of the Gamma by the Delta variant in Brazil: impact of lineage displacement on the ongoing pandemic
Giovanetti, M., Fonseca, V., Wilkinson, E., Tegally, H., San, E. J., Althaus, C. L., Xavier, J., Nanev Slavov, S., Viala, V. L., Ranieri Jeronimo Lima, A., Ribeiro, G., Souza-Neto, J. A., Fukumasu, H., Lehmann Coutinho, L., Venancio da Cunha, R., Freitas, C., Campelo de A e Melo, C. F., Navegantes, W., do Carmo Said, R. F., Almiron, M., de Oliveira, T., Sampaio, S. C., Elias, M. C., Tadeu Covas, D., Holmes, E. C., Lourenco, J., Kashima, S., Alcantara, L. C. J.
10.1101/2021.12.27.21268309 — Posted: 2021-12-29
Waning of SARS-CoV-2 booster viral-load reduction effectiveness
Levine-Tiefenbrun, M., Yelin, I., Alapi, H., Herzel, E., Kuint, J., Chodick, G., Gazit, S., Patalon, T., Kishony, R.
10.1101/2021.12.27.21268424 — Posted: 2021-12-29
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (BBV152) in children from 2 to 18 years of age: an open-label, age-de-escalation phase 2/3 study
Vadrevu, K. M., Reddy, S., Jogdand, H., Ganneru, B., Mirza, N., Tripathy, V., Singh, C., Khalatkar, V., Prasanth, S., Rai, S., Ella, R., Blackwelder, W., Prasad, S., Ella, K.
10.1101/2021.12.28.21268468 — Posted: 2021-12-29
Effects of COVID-19 on the human central olfactory system: a natural pre-post experiment
Thunell, E., Peter, M. G., Lenoir, V., Andersson, P., Landis, B. N., Becker, M., Lundstrom, J. N.
10.1101/2021.12.27.21268455 — Posted: 2021-12-29
A preliminary study of commercially available general-purpose chest radiography artificial intelligence-based software for detecting airspace opacity lesions in COVID-19 patients
Suzuki, M., Niimura, A., Nakamura, Y., Otsuka, Y.
10.1101/2021.12.22.21268176 — Posted: 2021-12-29
Neutralizing antibody responses to SARS-CoV-2: a population based seroepidemiological analysis in Delhi, India
Sharma, P., Gupta, E., Basu, S., Aggarwal, R., Mishra, S., Kale, P., Mundeja, N., Charan, B. S., Singh, G. K., SINGH, M. M.
10.1101/2021.12.28.21268472 — Posted: 2021-12-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).